From the Journals
From the Journals
Aspirin warning: Anemia may increase with daily use
“We found that low-dose aspirin also increased the risk of anemia during the trial, and this was most likely due to bleeding that was not...
From the Journals
Low-carb, plant-rich diets tied to breast cancer survival?
“Breast cancer survivors could benefit from limiting intake of carbohydrates, especially from fruit juice, sugar-sweetened beverages, and added...
Clinical Edge Journal Scan
Breast cancer and thyroid cancer: What is the link?
Clinical Edge Journal Scan
Family history of breast cancer in first-degree relatives may increase risk for certain cancers in men
From the Journals
Electronic nose may sniff out early lung cancer in COPD
Molecular profiling of exhaled breath using electronic nose (eNose) technology has shown potential as a method of early detection by identifying...
From the Journals
Ibrutinib + venetoclax: High-risk features don’t lessen CLL response
Expert cautions that upfront targeted therapies for CLL should be considered experimental, given the adverse events and lack of long-term follow-...
Latest News
Antibiotic prophylaxis may lower SSIs in skin cancer surgery
There’s a lack of evidence from randomized clinical trials of the role of antibiotic prophylaxis in reducing SSI rates among patients undergoing...
From the Journals
Cognitive decline risk in adult childhood cancer survivors
“We need to educate oncologists and primary care providers on the risks our survivors face long after completion of therapy.”
From the Journals
Risk of falls seen with newer antiandrogens for prostate cancer
The take-home message is that the findings give men – and the physicians who counsel them – a fuller idea of what to expect when considering using...
Latest News
Guide explains nonsurgical management of major hemorrhage
Bleeding affects everybody in medicine, from family doctors in smaller institutions who work in emergency departments to obstetricians and...
From the Journals
Safe to stop immunotherapy at 2 years in stable lung cancer
“These data may provide reassurance to us and patients that discontinuing treatment at 2 years can confer the same overall survival as extended...